-

AstraZeneca Awards 30 Nonprofit Organizations through the ACT on Health Equity Community Solutions Challenge to Actively Address Health Disparities

In its inaugural year, this challenge demonstrates one part of AstraZeneca’s long-term commitment to identify and invest in solutions to advance health equity in partnership with the external community

Recipient organizations from all across the country will deliver programs that take a community-based approach to improve local health outcomes

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca is proud to announce contributions to 30 nonprofit, community-based organizations nationwide through the ACT on Health Equity: Community Solutions Challenge. Recipients will use the funds to accelerate positive change for underserved populations at the local level.

“AstraZeneca is committed to advancing health equity in the US and we realize that this can only be done in partnership with local community leaders. The Community Solutions Challenge is a deliberate addition to our giving strategy which we believe is fundamental to achieving greater impact. We must work together at the community level in our schools, homes and communities to address the factors that contribute to inequities,” said Martha Orzechowski, Head, US Advocacy & Alliance, Corporate Affairs. “This distinguished group of organizations is leading change and making a direct, positive impact on underserved populations in all regions of the country.”

The AstraZeneca ACT on Health Equity: Community Solutions Challenge is part of Accelerate Change Together on Health Equity, AstraZeneca’s long-term commitment to identify and invest in solutions to advance health equity in partnership with the external community. Applicants were invited to apply under two focuses—Community Health and Wellbeing or Youth STEM Education and Career Readiness. In its inaugural year, more than 1,350 applications were received representing 49 US states. ACT on Health Equity is informed by the AstraZeneca Health Equity Advisory Council, a distinguished group of national experts and is committed to making an impact on the health and wellbeing of all people.

“The COVID-19 pandemic is a wake-up call from Mother Nature; misinformation is real, trust matters and the health promotion message must be culturally matched with the right messenger. By working together today, we can make a better tomorrow - where science will help ensure everyone has a chance to be as healthy as possible,” said Dr. Stephen B. Thomas, member of the AstraZeneca Health Equity Advisory Council, professor and Director of the Center for Health Equity at the University of Maryland School of Public Health in College Park, MD.

Recipient organizations are taking innovative and tailored approaches to improve outcomes for their communities - from ensuring science comes to life for public school students in New Mexico, to providing support for Burmese immigrants in Indiana. Below is a regional snapshot of the nonprofit organizations awarded. For more information, please visit the AstraZeneca US blog.

Northeast
Community Servings, Inc. – Massachusetts
YOU, Inc. – Worcester, Massachusetts

Mid-Atlantic
After-School All-Stars – Philadelphia, Pennsylvania and Camden, New Jersey
Big Picture Philadelphia – Philadelphia, Pennsylvania
Delaware Breast Cancer Coalition – Delaware
Esperanza – Philadelphia, Pennsylvania
Genesys Works – New York City, New York
Kid Power, Inc. – Washington, District of Columbia
Luminis Health Anne Arundel Medical Center – Anne Arundel and Prince George’s Counties, Maryland
The Academy of Natural Sciences of Drexel University – Philadelphia, Pennsylvania
The Police Athletic League – New York, New York
The Upstate Foundation – Syracuse, New York
Towson University Foundation, Inc. – Maryland
YWCA Tri County Area – Pottstown, Pennsylvania

South
Coastal Bend Wellness Foundation – San Antonio, Texas
Code/Art – South Florida
Eva’s Heroes – Texas
Florida Justice Center – Broward and Miami-Dade Counties, Florida
Public Health Institute – Albuquerque, New Mexico
Santa Fe Alliance for Science – Santa Fe, New Mexico

Midwest
Femergy – Central Ohio
Franciscan Health Foundation – Southern Indianapolis
LAHC - Leaders Advancing & Helping Communities – Dearborn, Michigan
Medical Organization for Latino Advancement – Illinois
Partnership for Innovation in Education – Ohio
Saint Anthony Hospital – West and Southside Chicago, Illinois

West
Adolescent Counseling Services – Santa Clara and San Mateo, California
Montana State University Foundation – Montana
Multiplier - Nest for Families – Hawaii
New Village Girls Academy – Los Angeles, California

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.

US-48947 Last Updated 1/21

Contacts

Media Inquiries
Brendan McEvoy
+1 302 885 2677
US Media Mailbox: usmediateam@astrazeneca.com

AstraZeneca

NASDAQ:AZN

Release Versions

Contacts

Media Inquiries
Brendan McEvoy
+1 302 885 2677
US Media Mailbox: usmediateam@astrazeneca.com

More News From AstraZeneca

AstraZeneca plans $2 billion manufacturing investment in Maryland, supporting 2,600 jobs and catalyzing economic growth

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its flagship biologics manufacturing facility in Frederick and construction of a new state-of-the-art facility in Gaithersburg for the development and clinical supply of innovative molecules to be used in clinical trials. The investment will support 2,600 jobs across the two sites in the state includin...

AstraZeneca unveils expanded manufacturing facility in Texas

COPPELL, Texas--(BUSINESS WIRE)--AstraZeneca today announces the unveiling of its newly-expanded, state-of-the-art manufacturing facility in Coppell, Texas. The expansion project will double the production of Lokelma for the benefit of patients in the United States and around the world. The investment of $445 million to expand the facility follows the groundbreaking last week at AstraZeneca’s manufacturing facility in Albemarle County, Virginia. Both are part of AstraZeneca’s $50 billion invest...

AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces that it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500m to support the enhanced manufacturing capability of a broader range of medicines including cancer treatments. This is part of the historic $50 billion investment announced in July 2025. The new facility will be located at Rivanna Futures in Albemarle County and is expected to create approximately 3,600 direct and indirect job...
Back to Newsroom